The ADVANCE Study at Yale is a treatment study examining the use of Varenicline (Chantix) to reduce alcohol consumption.
We are looking for heavy drinkers who smoke cigarettes and would like to reduce or stop drinking.
All treatment is strictly confidential and free of charge. If eligible, you can earn up to $525 for participating.
Click the links above to obtain more information regarding the Advance Study, and to see if you’re eligible.
Address: 1 Long Wharf Drive, SATU, Box 18, New Haven, CT, 06511
Sponsored by the National Institutes of Health and Yale School of Medicine